Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT NO. 1 TO FORM 10-K - ZIOPHARM ONCOLOGY INC | d558258d10ka.htm |
| EX-23.1 - EX-23.1 - ZIOPHARM ONCOLOGY INC | d558258dex231.htm |
| EX-32.1 - EX-32.1 - ZIOPHARM ONCOLOGY INC | d558258dex321.htm |
| EX-32.2 - EX-32.2 - ZIOPHARM ONCOLOGY INC | d558258dex322.htm |
| EX-31.2 - EX-31.2 - ZIOPHARM ONCOLOGY INC | d558258dex312.htm |
| EX-31.1 - EX-31.1 - ZIOPHARM ONCOLOGY INC | d558258dex311.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the incorporation by reference of the report of Caturano and Company, P.C. (whose name has since been changed to Caturano and Company, Inc.) dated March 17, 2010 relating to the financial statements of ZIOPHARM Oncology, Inc. for the period from September 9, 2003 (date of inception) through December 31, 2009, included in or made part of this Form 10-K/A, into the Company’s previously filed Registration Statements on Forms S-8 (File Nos. 333-129884, 333-134280, 333-142701, 333-160496 and 333-185433) and Forms S-3 (File Nos. 333-129680, 333-134279, 333-141014, 333-161453, 333-162160, 333-163517, 333-166444, 333-174292 and 333-177793).
| /s/ Caturano and Company, Inc. |
| Boston, Massachusetts March 18, 2013 |